Novel new drug approvals in 2016 were half of what they were in 2015. How many were first in class? How many received priority review? Our infographic tells the tale:
Novel new drug approvals in 2016 were half of what they were in 2015. How many were first in class? How many received priority review? Our infographic tells the tale:
© 2025 CLD. All Rights Reserved , Custom Learning Designs (CLD), Inc.